IMPETO MEDICAL has completed a second round financing with the French holding HRE on june 1st, 2008. The contract secures funding of IMPETO MEDICAL’s ambitious R&D and marketing strategy.

IMPETO MEDICAL announces SFDA registration approval of it’s EZSCAN device by the Chinese Authorities as of july 28th, 2008. The registration allows for immediate commercialisation of the device on the Chinese market.

EZSCAN is first presented at the 5th World Congress on Prevention of Diabetes and its complications (WCPD) in Helsinki, June 1-4 2008.